The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, I.-W.
Right arrow Articles by Groopman, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, I.-W.
Right arrow Articles by Groopman, J. E.
The Journal of Immunology, 2001, 167: 2766-2771.
Copyright © 2001 by The American Association of Immunologists

HIV-1 Tat Induces Microvascular Endothelial Apoptosis Through Caspase Activation1

In-Woo Park, Christina K. Ullrich, Elena Schoenberger, Ramesh K. Ganju and Jerome E. Groopman2

Division of Experimental Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115

HIV-1 Tat, in addition to its critical role in viral transcription, is secreted from infected cells and can act as a proto-cytokine. We studied the effects of HIV-1 Tat in primary human microvascular endothelial cells of lung origin and found that it caused apoptosis. This apoptosis occurred without induction of either Fas or TNF, known mediators of programmed cell death. Tat, like Fas ligand, induced cleavage of chromatin structure, as evidenced by changes in DNA laddering, incorporation of fluorescein into the nicked chromosomal DNA (TUNEL assay), and mono- or oligonucleosomes. Furthermore, Tat treatment caused cleavage of poly(A/DP)-ribose polymerase, a substrate of caspases. Caspase-3, but not caspase-9, was activated following treatment of primary human microvascular endothelial cells of lung origin with either Tat or anti-Fas agonist Ab (anti-Fas). Inhibition of caspase-3 activity markedly reduced apoptosis. Although Fas-mediated apoptosis involved changes in Bcl-2, Bax, and Bad regulatory proteins, such alterations were not observed with Tat. Taken together, these data demonstrate that HIV-1 Tat is able to activate apoptosis in microvascular endothelium by a mechanism distinct from TNF secretion or the Fas pathway.




This article has been cited by other articles:


Home page
ThoraxHome page
I Petrache, K Diab, K S Knox, H L Twigg III, R S Stephens, S Flores, and R M Tuder
HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism
Thorax, May 1, 2008; 63(5): 463 - 469.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. F. Wu, Z. Ma, D. P. Myers, and L. S. Terada
HIV-1 Tat Activates Dual Nox Pathways Leading to Independent Activation of ERK and JNK MAP Kinases
J. Biol. Chem., December 28, 2007; 282(52): 37412 - 37419.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. L. Caldwell, R. Gadipatti, K. B. Lane, and V. L. Shepherd
HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells
J. Leukoc. Biol., January 1, 2006; 79(1): 192 - 201.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-S. Kim, J.-M. Kim, D.-L. Jung, J.-E. Kang, S. Lee, J. S. Kim, W. Seol, H.-C. Shin, H. S. Kwon, C. Van Lint, et al.
Artificial Zinc Finger Fusions Targeting Sp1-binding Sites and the trans-Activator-responsive Element Potently Repress Transcription and Replication of HIV-1
J. Biol. Chem., June 3, 2005; 280(22): 21545 - 21552.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Aoki and G. Tosato
HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity
Blood, August 1, 2004; 104(3): 810 - 814.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
P. L. Kimmel, L. Barisoni, and J. B. Kopp
Pathogenesis and Treatment of HIV-Associated Renal Diseases: Lessons from Clinical and Animal Studies, Molecular Pathologic Correlations, and Genetic Investigations
Ann Intern Med, August 5, 2003; 139(3): 214 - 226.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T.-A. Kim, H. K. Avraham, Y.-H. Koh, S. Jiang, I.-W. Park, and S. Avraham
HIV-1 Tat-Mediated Apoptosis in Human Brain Microvascular Endothelial Cells
J. Immunol., March 1, 2003; 170(5): 2629 - 2637.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. A. Bozzette, C. F. Ake, H. K. Tam, S. W. Chang, and T. A. Louis
Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection
N. Engl. J. Med., February 20, 2003; 348(8): 702 - 710.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Twu, N. Q. Liu, W. Popik, M. Bukrinsky, J. Sayre, J. Roberts, S. Rania, V. Bramhandam, K. P. Roos, W. R. MacLellan, et al.
Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways
PNAS, October 29, 2002; 99(22): 14386 - 14391.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. C. Xu, R. F. Wu, Y. Gu, Y.-S. Yang, M.-C. Yang, F. E. Nwariaku, and L. S. Terada
Involvement of TRAF4 in Oxidative Activation of c-Jun N-terminal Kinase
J. Biol. Chem., July 26, 2002; 277(31): 28051 - 28057.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Hay and G. Kannourakis
A time to kill: viral manipulation of the cell death program
J. Gen. Virol., June 1, 2002; 83(7): 1547 - 1564.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. G. Prikhod'ko, E. A. Prikhod'ko, A. G. Pletnev, and J. I. Cohen
Langat Flavivirus Protease NS3 Binds Caspase-8 and Induces Apoptosis
J. Virol., May 3, 2002; 76(11): 5701 - 5710.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.